B-1025S-5 Search Results


94
Vector Laboratories biotinylated swga magnetic beads
ONX-0914 inhibits prostate cancer progression by promoting TCF7L1 O-GlcNAcylation and subsequently suppressing AR expression. ( A ) Venn diagram showing 13 overlapping AR-associated transcription factors identified from bioinformatic analyses integrating JASPAR, TCGA, and GEO datasets comparing AR-high vs. AR-low prostate cancer samples. ( B ) AR expression changes of candidate transcription factors in LNCaP cells treated with ONX-0914, based on qPCR screening. ( C ) qPCR analyses showing that AR expression is suppressed following TCF7L1 overexpression (OE TCF7L1) and upregulated following TCF7L1 knockdown (si TCF7L1). ( D ) Immunoblot analysis confirming AR expression is suppressed following OE TCF7L1 and upregulated following si TCF7L1. ( E ) Immunoblot analysis showing that TCF7L1 upregulation by ONX-0914 is reversed by DON. ( F ) Co-immunoprecipitation (Co-IP) using anti-HA antibody in HA-tagged TCF7L1-overexpressing cells reveals O-GlcNAcylation of TCF7L1. ( G ) <t>sWGA</t> pull-down confirms that TCF7L1 is O-GlcNAc modified; modification is enhanced by PUGNAc and suppressed by OSMI-1. ( H , I ) Co-IP assays performed with anti-HA ( H ) or anti-Flag ( I ) in HA-TCF7L1/Flag-OGT co-transfected cells, demonstrating their interaction. ( J ) Co-IP shows native TCF7L1 also interacts with endogenous OGT in LNCaP cells. ( K ) Co-IP analysis shows ONX-0914 increases TCF7L1 O-GlcNAcylation. ( L ) sWGA pull-down further validates that ONX-0914 promotes O-GlcNAcylation of TCF7L1 in LNCaP cells. ( M ) Cell colony images showing reduced colonies density and proliferation in the OE TCF7L1 group compared to NC and siTCF7L1. ( N ) Quantification of cell colonies in each group. ( O ) CCK-8 assay demonstrates suppressed proliferation following TCF7L1 overexpression. ( P , Q ) Transwell assays and quantification indicate significantly reduced migration and invasion in the OE TCF7L1 group compared to controls. ( R , S ) qPCR ( R ) profiling of EMT-related transcripts and immunoblot ( S ) detection of EMT-associated proteins in NC, OE TCF7L1, and si TCF7L1 groups.
Biotinylated Swga Magnetic Beads, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/B-1025S-5/Biotinylated%2C+succinylated+Wheat+Germ+Agglutinin+(WGA)/pmc13040289-84-9-13
Average 94 stars, based on 1 article reviews
biotinylated swga magnetic beads - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


ONX-0914 inhibits prostate cancer progression by promoting TCF7L1 O-GlcNAcylation and subsequently suppressing AR expression. ( A ) Venn diagram showing 13 overlapping AR-associated transcription factors identified from bioinformatic analyses integrating JASPAR, TCGA, and GEO datasets comparing AR-high vs. AR-low prostate cancer samples. ( B ) AR expression changes of candidate transcription factors in LNCaP cells treated with ONX-0914, based on qPCR screening. ( C ) qPCR analyses showing that AR expression is suppressed following TCF7L1 overexpression (OE TCF7L1) and upregulated following TCF7L1 knockdown (si TCF7L1). ( D ) Immunoblot analysis confirming AR expression is suppressed following OE TCF7L1 and upregulated following si TCF7L1. ( E ) Immunoblot analysis showing that TCF7L1 upregulation by ONX-0914 is reversed by DON. ( F ) Co-immunoprecipitation (Co-IP) using anti-HA antibody in HA-tagged TCF7L1-overexpressing cells reveals O-GlcNAcylation of TCF7L1. ( G ) sWGA pull-down confirms that TCF7L1 is O-GlcNAc modified; modification is enhanced by PUGNAc and suppressed by OSMI-1. ( H , I ) Co-IP assays performed with anti-HA ( H ) or anti-Flag ( I ) in HA-TCF7L1/Flag-OGT co-transfected cells, demonstrating their interaction. ( J ) Co-IP shows native TCF7L1 also interacts with endogenous OGT in LNCaP cells. ( K ) Co-IP analysis shows ONX-0914 increases TCF7L1 O-GlcNAcylation. ( L ) sWGA pull-down further validates that ONX-0914 promotes O-GlcNAcylation of TCF7L1 in LNCaP cells. ( M ) Cell colony images showing reduced colonies density and proliferation in the OE TCF7L1 group compared to NC and siTCF7L1. ( N ) Quantification of cell colonies in each group. ( O ) CCK-8 assay demonstrates suppressed proliferation following TCF7L1 overexpression. ( P , Q ) Transwell assays and quantification indicate significantly reduced migration and invasion in the OE TCF7L1 group compared to controls. ( R , S ) qPCR ( R ) profiling of EMT-related transcripts and immunoblot ( S ) detection of EMT-associated proteins in NC, OE TCF7L1, and si TCF7L1 groups.

Journal: Oncology Research

Article Title: ONX-0914 Suppresses Hormone-Sensitive Prostate Cancer by Promoting O-GlcNAcylation-Mediated Stabilization of TCF7L1

doi: 10.32604/or.2026.073156

Figure Lengend Snippet: ONX-0914 inhibits prostate cancer progression by promoting TCF7L1 O-GlcNAcylation and subsequently suppressing AR expression. ( A ) Venn diagram showing 13 overlapping AR-associated transcription factors identified from bioinformatic analyses integrating JASPAR, TCGA, and GEO datasets comparing AR-high vs. AR-low prostate cancer samples. ( B ) AR expression changes of candidate transcription factors in LNCaP cells treated with ONX-0914, based on qPCR screening. ( C ) qPCR analyses showing that AR expression is suppressed following TCF7L1 overexpression (OE TCF7L1) and upregulated following TCF7L1 knockdown (si TCF7L1). ( D ) Immunoblot analysis confirming AR expression is suppressed following OE TCF7L1 and upregulated following si TCF7L1. ( E ) Immunoblot analysis showing that TCF7L1 upregulation by ONX-0914 is reversed by DON. ( F ) Co-immunoprecipitation (Co-IP) using anti-HA antibody in HA-tagged TCF7L1-overexpressing cells reveals O-GlcNAcylation of TCF7L1. ( G ) sWGA pull-down confirms that TCF7L1 is O-GlcNAc modified; modification is enhanced by PUGNAc and suppressed by OSMI-1. ( H , I ) Co-IP assays performed with anti-HA ( H ) or anti-Flag ( I ) in HA-TCF7L1/Flag-OGT co-transfected cells, demonstrating their interaction. ( J ) Co-IP shows native TCF7L1 also interacts with endogenous OGT in LNCaP cells. ( K ) Co-IP analysis shows ONX-0914 increases TCF7L1 O-GlcNAcylation. ( L ) sWGA pull-down further validates that ONX-0914 promotes O-GlcNAcylation of TCF7L1 in LNCaP cells. ( M ) Cell colony images showing reduced colonies density and proliferation in the OE TCF7L1 group compared to NC and siTCF7L1. ( N ) Quantification of cell colonies in each group. ( O ) CCK-8 assay demonstrates suppressed proliferation following TCF7L1 overexpression. ( P , Q ) Transwell assays and quantification indicate significantly reduced migration and invasion in the OE TCF7L1 group compared to controls. ( R , S ) qPCR ( R ) profiling of EMT-related transcripts and immunoblot ( S ) detection of EMT-associated proteins in NC, OE TCF7L1, and si TCF7L1 groups.

Article Snippet: The treated samples were incubated overnight at 4°C with biotinylated sWGA magnetic beads (Vector Laboratories, B-1025S-5, Newark, CA, USA).

Techniques: Expressing, Over Expression, Knockdown, Western Blot, Immunoprecipitation, Co-Immunoprecipitation Assay, Modification, Transfection, CCK-8 Assay, Migration